Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder while Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder while breastfeeding. We will also discuss about common side effects and warnings associated with Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder.

What is Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder used for?


ANORO ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Important Limitations of Use ANORO ELLIPTA is NOT indicated for the relief of acute bronchospasm or for the treatment of asthma. The safety and efficacy of ANORO ELLIPTA in asthma have not been established. ANORO ELLIPTA is a combination of umeclidinium, an anticholinergic, and vilanterol, a long-acting beta2-adrenergic agonist (LABA), indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). (1) Important limitations of use: Not indicated for relief of acute bronchospasm or for the treatment of asthma. (1, 5.2)

Is using Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder safe or dangerous while breastfeeding?

Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder is made up of Umeclidinium, Vilanterol.Below is the analysis of usage of its active ingredients while breastfeeding, We suggest you to go through full analysis to understand the impact of Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder in breastfeeding.Please note that we have already provided safety rating to some of the ingredients but other ingredients does not have any safety rating and we are working on it.

Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder Breastfeeding Analsys


Vilanterol while Breastfeeding

Safe

Long-acting bronchodilator with a similar action than Salmeterol. At latest update no published data on excretion into breast milk were found. Plasma concentration after having inhaled bronchodilators is very low, so that a significant amount in the breast milk is not expected (Ellsworth 1994, McDonald 1996).Its low oral bioavailability hinders the passage from ingested milk towards the infant’s plasma, except in preterm babies and immediate neonatal period, which may show an increased intestinal permeability. Terbutaline, a molecule of the same family, is excreted in insignificant amounts in breast milk (Lindberg 1984). Inhaled bronchodilators are preferred because of their lower doses (less risk of excretion into milk).

Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder Breastfeeding Analsys - 2


Umeclidinium while Breastfeeding

CAS Number: 869185-19-3

Although no published data exist on the use of umeclidinium during breastfeeding, it produces low systemic maternal serum levels and any drug in breastmilk are not likely to be absorbed by the infant. The risk to the breastfed infant of maternal umeclidinium inhalation is small. Combination products such as Anoro Ellipta are likely to be acceptable for similar reasons.

Vilanterol while Breastfeeding

CAS Number: 503068-34-6

Although no published data exist on the use of vilanterol during lactation, data from the related drug, terbutaline, indicate that very little is expected to be excreted into breastmilk.[1] Vilanterol is available only in combination products such as Breo Ellipta and Anoro Ellipta. The authors of several reviews agree that use of inhaled bronchodilators is acceptable during breastfeeding because of the low bioavailability and maternal serum levels after use.[2][3][4][5] Combination products such as Breo Ellipta and Anoro Ellipta are likely to be acceptable for similar reasons.


What should I do if already breastfed my kid after using Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder?

We are not completely sure about safety of Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder in breastfeeding. We would suggest you to contact your doctor or health care provider and explain your situation with Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder. If you observe anything abnormal with your baby please call 911 or contact emergency services in your area.


My doctor has prescribed me Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder, what should I do?

If your doctor considers Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder safe enough to prescribe for you that means its benefits outweigh its known risks.


If I am using Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder, will my baby need extra monitoring?

Not Sure, Please check with your doctor or lactation consultant.


Who can I talk to if I have questions about usage of Anoro Ellipta | Umeclidinium Bromide And Vilanterol Trifenatate Powder in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week